Takeda Pharmaceutical Co., Ltd./ JP3463000004 /
24/05/2024 18:50:19 | Chg. -0.2300 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
26.0600USD | -0.87% | 381 Turnover: 9,928.8600 |
-Bid Size: - | -Ask Size: - | 41.66 bill.USD | - | - |
GlobeNewswire
16/10/2019
Global RNA-Targeted Small Molecules Study, 2019: A Landscape Analysis of Companies, Technologies, Ta...
GlobeNewswire
10/07/2019
Worldwide Proton Pump Inhibitors (PPIs) Markets to 2023 with AstraZeneca, Bayer, Johnson & Johnson S...
GlobeNewswire
28/06/2019
Global Pericarditis Drugs Market Research Report 2019-2023 - Key Players are AstraZeneca, Bayer, Joh...
GlobeNewswire
18/06/2019
White Oil: $2.71Bn World Market Insights & Outlook to 2025 with Sonneborn, Sinopec, Nynas, Royal Dut...
GlobeNewswire
25/04/2019
Integrin Alpha 4 Therapeutics Pipeline Report, H1 2019 - Review of 9 Companies, Drug Profiles & Feat...
GlobeNewswire
08/04/2019
World Primary Immune Deficiency (PID) Therapeutics Pipeline Report, H1 2019 Edition with Review of K...
GlobeNewswire
31/01/2019
Gastrointestinal Diseases Pipeline Review, 2018 - Which Companies are the Most Active within Each Pi...
GlobeNewswire
21/01/2019
Global Women's Health Drugs Market Report 2019-2024 Featuring AbbVie Allergan Bayer, GlaxoSmithKline...
GlobeNewswire
17/12/2018
The Global Market for Cell Separation & Characterization in Solid Tumors (2018-2023): Abbvie, AstraZ...
GlobeNewswire
17/09/2018
World Vaccines (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, P...
GlobeNewswire
30/08/2018
Mesoblast Reports Fourth Quarter and Full-Year 2018 Financial Results and Operational Highlights